Furthermore, in a study showing the importance of NK cell dysfunction in multiple myeloma, ICOS expression levels were found to be higher in bone marrow CD56bright NK cells from relapsed/refractory patients, while TIGIT and TIM3 were increased [31]. Here, ICOS is linked to plasma cell myeloma.